Effect of nigella sativa on IL-10 in MB leprosy that received MDT-WHO therapy
Background: Leprosy, a chronic infectious disease presents a broad clinical spectrum that is correlated with the immunological response of the patient, mainly related to Th1/Th2 cells. IL-10 is a major cytokine produced by Th2 cells inhibits imunostimulatory cytokine produced by Th1 cells. Suppressi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Diponegoro University
2016-07-01
|
Series: | Journal of Biomedicine and Translational Research |
Subjects: | |
Online Access: | http://ejournal2.undip.ac.id/index.php/jbtr/article/view/438 |
_version_ | 1818149028572954624 |
---|---|
author | Febrina Primasanti Lewie Suryaatmadja R. Sri Djoko |
author_facet | Febrina Primasanti Lewie Suryaatmadja R. Sri Djoko |
author_sort | Febrina Primasanti |
collection | DOAJ |
description | Background: Leprosy, a chronic infectious disease presents a broad clinical spectrum that is correlated with the immunological response of the patient, mainly related to Th1/Th2 cells. IL-10 is a major cytokine produced by Th2 cells inhibits imunostimulatory cytokine produced by Th1 cells. Suppressive effects of IL-10 in monocytes and cytokine synthesis by Th1 cells presumably because IL-10 has a general suppressive effect on immune function. Nigella sativa has a potent potentiating effect on cellular immunity through suppression of Th2 cells and IL-10, resulting in potentiation of Th1 cells.
Method: The study design is a randomized pretest and posttest controlled design involving 40 subjects of MB leprosy patients. Serum levels of IL-10 were measured by ELISA.
Result: The mean decrease in serum levels of IL-10 (IL-10 delta) in the treatment group (average fell 3.12 pg/ml) is greater than the control group (average rose 0.21 pg/ml), where the difference is statistically significant (p = 0.029). Nigella sativa giving significant correlation with a decrease in IL-10 compared to the control group (p=0.044, OR: 10.23).
Conclusion: supplementation of Nigella sativa 3 x 1000 mg for 2 months in patients with MB leprosy can reduce levels of IL-10, thus increasing the cellular immune response in patients with MB leprosy. |
first_indexed | 2024-12-11T13:00:31Z |
format | Article |
id | doaj.art-26cf1b49280b457086f24f86c13e5998 |
institution | Directory Open Access Journal |
issn | 2503-2178 |
language | English |
last_indexed | 2024-12-11T13:00:31Z |
publishDate | 2016-07-01 |
publisher | Diponegoro University |
record_format | Article |
series | Journal of Biomedicine and Translational Research |
spelling | doaj.art-26cf1b49280b457086f24f86c13e59982022-12-22T01:06:29ZengDiponegoro UniversityJournal of Biomedicine and Translational Research2503-21782016-07-01215910.14710/jbtr.v2i1.438475Effect of nigella sativa on IL-10 in MB leprosy that received MDT-WHO therapyFebrina Primasanti0Lewie Suryaatmadja1R. Sri Djoko2Faculty of Medicine Diponegoro University/ Dr. Kariadi Hospital Semarang, IndonesiaFaculty of Medicine Diponegoro University/ Dr. Kariadi Hospital Semarang, IndonesiaFaculty of Medicine Diponegoro University/ Dr. Kariadi Hospital Semarang, IndonesiaBackground: Leprosy, a chronic infectious disease presents a broad clinical spectrum that is correlated with the immunological response of the patient, mainly related to Th1/Th2 cells. IL-10 is a major cytokine produced by Th2 cells inhibits imunostimulatory cytokine produced by Th1 cells. Suppressive effects of IL-10 in monocytes and cytokine synthesis by Th1 cells presumably because IL-10 has a general suppressive effect on immune function. Nigella sativa has a potent potentiating effect on cellular immunity through suppression of Th2 cells and IL-10, resulting in potentiation of Th1 cells. Method: The study design is a randomized pretest and posttest controlled design involving 40 subjects of MB leprosy patients. Serum levels of IL-10 were measured by ELISA. Result: The mean decrease in serum levels of IL-10 (IL-10 delta) in the treatment group (average fell 3.12 pg/ml) is greater than the control group (average rose 0.21 pg/ml), where the difference is statistically significant (p = 0.029). Nigella sativa giving significant correlation with a decrease in IL-10 compared to the control group (p=0.044, OR: 10.23). Conclusion: supplementation of Nigella sativa 3 x 1000 mg for 2 months in patients with MB leprosy can reduce levels of IL-10, thus increasing the cellular immune response in patients with MB leprosy.http://ejournal2.undip.ac.id/index.php/jbtr/article/view/438MB Leprosy, Nigella sativa, IL-10 |
spellingShingle | Febrina Primasanti Lewie Suryaatmadja R. Sri Djoko Effect of nigella sativa on IL-10 in MB leprosy that received MDT-WHO therapy Journal of Biomedicine and Translational Research MB Leprosy, Nigella sativa, IL-10 |
title | Effect of nigella sativa on IL-10 in MB leprosy that received MDT-WHO therapy |
title_full | Effect of nigella sativa on IL-10 in MB leprosy that received MDT-WHO therapy |
title_fullStr | Effect of nigella sativa on IL-10 in MB leprosy that received MDT-WHO therapy |
title_full_unstemmed | Effect of nigella sativa on IL-10 in MB leprosy that received MDT-WHO therapy |
title_short | Effect of nigella sativa on IL-10 in MB leprosy that received MDT-WHO therapy |
title_sort | effect of nigella sativa on il 10 in mb leprosy that received mdt who therapy |
topic | MB Leprosy, Nigella sativa, IL-10 |
url | http://ejournal2.undip.ac.id/index.php/jbtr/article/view/438 |
work_keys_str_mv | AT febrinaprimasanti effectofnigellasativaonil10inmbleprosythatreceivedmdtwhotherapy AT lewiesuryaatmadja effectofnigellasativaonil10inmbleprosythatreceivedmdtwhotherapy AT rsridjoko effectofnigellasativaonil10inmbleprosythatreceivedmdtwhotherapy |